NanoViricides
NNVC
$1.10
Share price
-0.90%
Change (1 day)
-17.29%
Change (1 year)
Categories
NanoViricides (NNVC) - Net assets
Net assets on the balance sheet as of December 2023 : $12.45 M
According to NanoViricides's latest financial reports the company has $12.45 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
NanoViricides - Net assets on balance sheet (from 2006 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-06-30 | $14.86 M | -35.6% |
| 2022-06-30 | $23.08 M | -22.83% |
| 2021-06-30 | $29.91 M | 37.47% |
| 2020-06-30 | $21.75 M | 105.26% |
| 2019-06-30 | $10.6 M | -39.99% |
| 2018-06-30 | $17.66 M | -13.08% |
| 2017-06-30 | $20.32 M | -11.83% |
| 2016-06-30 | $23.04 M | -27.49% |
| 2015-06-30 | $31.78 M | 36.02% |
| 2014-06-30 | $23.36 M | 191.76% |
| 2013-06-30 | $8 M | -42.17% |
| 2012-06-30 | $13.85 M | 36.17% |
| 2011-06-30 | $10.17 M | 56.03% |
| 2010-06-30 | $6.51 M | 162.26% |
| 2009-06-30 | $2.48 M | 460.14% |
| 2008-06-30 | $0.44 M | -11.31% |
| 2007-06-30 | $0.5 M | -59.6% |
| 2006-06-30 | $1.23 M | -1976.31% |
| 2005-06-30 | $-0.07 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $22.74 B | 182,606.75% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 302,162.45% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 132,803.92% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 130,715.75% | 🇬🇧 UK |
 Novavax NVAX | -$0.72 B | -5,857.94% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$0.46 B | -3,758.54% | 🇺🇸 USA |